Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 USD | -25.00% | -.--% | -.--% |
2023 | Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2023 | Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.66M 365M |
---|---|---|---|---|---|
Net income 2021 | -2M -157M | Net income 2022 | -1M -78.32M | EV / Sales 2021 | - |
Net Debt 2021 | 3.53M 276M | Net Debt 2022 | 3.17M 248M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.34
x | P/E ratio 2022 |
-2
x | Employees | 3 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 67.35% |
1 day | -25.00% |
Managers | Title | Age | Since |
---|---|---|---|
Walter Messier
FOU | Founder | 69 | 31/10/90 |
Steve Warnecke
CEO | Chief Executive Officer | 68 | 31/08/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Warnecke
CEO | Chief Executive Officer | 68 | 31/08/10 |
Mark Boggess
BRD | Director/Board Member | 64 | 31/12/09 |
Founder | 74 | 31/10/90 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.99M | |
+46.19% | 55.7B | |
-6.14% | 39.57B | |
+40.06% | 39.91B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
-0.35% | 12.12B | |
+24.18% | 12.12B | |
+28.38% | 12.17B |
- Stock Market
- Equities
- FNAM Stock